PUBLIC COMPANY
save$INKTMiNK Therapeutics, Inc.
$INKT11.62+2.33%New York, NY, USupdated 10h ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
3
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
Insider activity
source: SEC Form 4🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that